We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Adding links to content, making them accessible and GOV.UK's external linking policy.
Find guidance and technical specifications for software developers on the IRmark.
The European Trade Mark and Design Network has updated its common practice on the general indications of the Nice classification headings in accordance with European Union Trade Mark Regulation No. 2015/2424.
It is the only example globally of an end-to-end access pathway, where a medicine developer can work collaboratively with the national health system, the regulator, and health technology assessment bodies from the early stages of clinical development.
UK Science and Tech Secretary announces renewed push to turbo-charge UK-EU science and technology links, to tackle shared global challenges.
The Innovative Licensing and Access Pathway (ILAP) is focussed on getting the most transformative new medicines, to patients in the UK health system more quickly.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).